| Dr Vijaya Gopal Kotha, MD | |
|
215 North Ave, Mount Clemens, MI 48043-1716 | |
| (313) 580-6760 | |
| Not Available |
| Full Name | Dr Vijaya Gopal Kotha |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 41 Years |
| Location | 215 North Ave, Mount Clemens, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386657427 | NPI | - | NPPES |
| 4224674 | Medicaid | MI | |
| 26OE011140 | Other | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4301058577 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Macomb Oakland Hosp-warren Campus | Warren, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Ford Medical Group | 0547178311 | 2095 |
| Bal K Gupta Md Pc | 5193779189 | 3 |
| Henry Ford Macomb Hospital Corporation | 7911808381 | 276 |
News Archive
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the February 24 issue of JAMA.
Due to the aging Baby Boomer population, AMD, or Age-related Macular Degeneration, is expected to double by the year 2020.
New findings reveal how a mutation, a change in the genetic code that causes neurodegeneration, alters the shape of DNA, making cells more vulnerable to stress and more likely to die.
› Verified 6 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144801 PECOS PAC ID: 0547178311 Enrollment ID: O20031105000139 |
News Archive
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the February 24 issue of JAMA.
Due to the aging Baby Boomer population, AMD, or Age-related Macular Degeneration, is expected to double by the year 2020.
New findings reveal how a mutation, a change in the genetic code that causes neurodegeneration, alters the shape of DNA, making cells more vulnerable to stress and more likely to die.
› Verified 6 days ago
| Entity Name | Henry Ford Macomb Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134265986 PECOS PAC ID: 7911808381 Enrollment ID: O20040119000142 |
News Archive
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the February 24 issue of JAMA.
Due to the aging Baby Boomer population, AMD, or Age-related Macular Degeneration, is expected to double by the year 2020.
New findings reveal how a mutation, a change in the genetic code that causes neurodegeneration, alters the shape of DNA, making cells more vulnerable to stress and more likely to die.
› Verified 6 days ago
| Entity Name | Bal K Gupta Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306937339 PECOS PAC ID: 5193779189 Enrollment ID: O20050311000898 |
News Archive
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the February 24 issue of JAMA.
Due to the aging Baby Boomer population, AMD, or Age-related Macular Degeneration, is expected to double by the year 2020.
New findings reveal how a mutation, a change in the genetic code that causes neurodegeneration, alters the shape of DNA, making cells more vulnerable to stress and more likely to die.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vijaya Gopal Kotha, MD 11900 E Twelve Mile Rd, Suite 111, Warren, MI 48093-3472 Ph: (586) 573-5300 | Dr Vijaya Gopal Kotha, MD 215 North Ave, Mount Clemens, MI 48043-1716 Ph: (313) 580-6760 |
News Archive
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the February 24 issue of JAMA.
Due to the aging Baby Boomer population, AMD, or Age-related Macular Degeneration, is expected to double by the year 2020.
New findings reveal how a mutation, a change in the genetic code that causes neurodegeneration, alters the shape of DNA, making cells more vulnerable to stress and more likely to die.
› Verified 6 days ago
Eric L Zimmerman, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1030 Harrington St Ste Ll001, Mount Clemens, MI 48043 Phone: 586-493-3297 | |
Dr. Margaret Samaan, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 215 North Ave, Mount Clemens, MI 48043 Phone: 586-466-9950 | |
Dr. Julie Anne-marie Burnham, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1030 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-3188 Fax: 586-493-3191 | |
Dr. Pravin N Soni, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 279 N Groesbeck Hwy, Mount Clemens, MI 48043 Phone: 586-627-0024 Fax: 586-627-0027 | |
Sara Razmjou-schwarz, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1030 Harrington St Ste Ll001, Mount Clemens, MI 48043 Phone: 586-493-8000 Fax: 586-493-3299 | |
Fedor Opochinsky, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 North Ave, Mount Clemens, MI 48043 Phone: 586-466-9939 Fax: 586-466-9956 |